申请人:Baschong Werner
公开号:US20080305055A1
公开(公告)日:2008-12-11
Compounds of the formulae (1), (2) and selected hindered nitroxyl, hydroxylamine and hydroxylamine salt compounds such as the compound of formula (3), wherein Gi is hydrogen; C
1
-C
22
alkyl; C
1
-C
22
alkylthio; C
2
-C
22
alkylthioalkyl; C
5
-C
7
cycloalkyl; phenyl; C
7
-C
9
phenylalkyl; or SO
3
M; G
2
is C
1
-C
22
alkyl; C
5
-C
7
cycloalkyl; phenyl; or C
7
-C
9
phenylalkyl; E is oxyl or hydroxyl; V is —O—; or —NH—; a is 0 or 1 or 2; b, c and d and g are each independently of one another 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently of one another an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G
3
are as defined in claim
1
; G
4
and G
5
are each independently of the other hydrogen; or C
1
-C
22
alkyl; exhibit marked antiinflammatory action.